Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2018-02-09

Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing

View source ↗

Summary

EMA recommends regular liver function tests for women taking Esmya (ulipristal acetate) during ongoing review of the medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmya (ulipristal acetate)